tiprankstipranks
Trending News
More News >
Pure Bioscience (PURE)
OTHER OTC:PURE
US Market

Pure Bioscience (PURE) Price & Analysis

Compare
44 Followers

PURE Stock Chart & Stats

$0.05
<$0.01(1.96%)
At close: 4:00 PM EST
$0.05
<$0.01(1.96%)

PURE FAQ

What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.04 and its highest was $0.21 in the past 12 months.
    What is Pure Bioscience’s market cap?
    Pure Bioscience’s market cap is $5.18M.
      When is Pure Bioscience’s upcoming earnings report date?
      Pure Bioscience’s upcoming earnings report date is Mar 18, 2026 which is in 83 days.
        How were Pure Bioscience’s earnings last quarter?
        Pure Bioscience released its earnings results on Dec 15, 2025. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
          Is Pure Bioscience overvalued?
          According to Wall Street analysts Pure Bioscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Pure Bioscience pay dividends?
            Pure Bioscience does not currently pay dividends.
            What is Pure Bioscience’s EPS estimate?
            Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Pure Bioscience have?
            Pure Bioscience has 111,886,475 shares outstanding.
              What happened to Pure Bioscience’s price movement after its last earnings report?
              Pure Bioscience reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Pure Bioscience?
                Currently, no hedge funds are holding shares in PURE
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Pure Bioscience

                  PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

                  Pure Bioscience (PURE) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Mannatech
                  United-Guardian
                  Tantech Holdings
                  Grove Collaborative Holdings
                  Yoshitsu Co. Ltd. Sponsored ADR

                  Ownership Overview

                  0.72%99.28%
                  Insiders
                  0.72% Other Institutional Investors
                  99.28% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks